text
stringlengths
81
4.38k
<s>[INST] Provide description for trial id: NCT03863457 [/INST] Patients with known or suspected primary or metastatic breast cancer with one lesion that is 1.5 cm in diameter or greater may be eligible for this study. Patients may participate in this study if they are at least 18 years of age. Up to 40 evaluable subj...
<s>[INST] Provide title for trial id: NCT03863457 [/INST] [18F] F-GLN by PET/CT in Breast Cancer </s>
<s>[INST] Provide the recruitment status for trial id: NCT03863457 [/INST] Recruiting </s>
<s>[INST] Provide the medical condition for trial id: NCT03863457 [/INST] Breast Cancer </s>
<s>Trial Id: Contrast Enhanced Spectral Mammography vs. MRI for Breast Cancer Screening Recruitment Status: Active, not recruiting Trail description: This research study is evaluating whether contrast enhanced mammography can be used as an alternative to breast Magnetic Resonance Imaging (MRI) for cancer screening Incl...
<s>[INST] Provide inclusion criteria for trial id: NCT03482557 [/INST] Prospective Patient Recruitment Women Age > or equal to 30 years Recommendation for breast biopsy has been made Recommendation for biopsy will result from an imaging work-up originating with a screening exam (mammogram, tomosynthesis, ultrasound, ...
<s>[INST] Provide exclusion criteria for trial id: NCT03482557 [/INST] Prospective Patient Recruitment Men Women with implants Participants who have a known allergy to contrast media. Participants who have a known severe allergic response to one or more allergens, defined as anaphylaxis Participants with poor asthma ...
<s>[INST] Provide description for trial id: NCT03482557 [/INST] This research study is evaluating whether contrast enhanced mammography can be used as an alternative to breast Magnetic Resonance Imaging (MRI) for cancer screening </s>
<s>[INST] Provide title for trial id: NCT03482557 [/INST] Contrast Enhanced Spectral Mammography vs. MRI for Breast Cancer Screening </s>
<s>[INST] Provide the recruitment status for trial id: NCT03482557 [/INST] Active, not recruiting </s>
<s>[INST] Provide the medical condition for trial id: NCT03482557 [/INST] Breast Cancer </s>
<s>Trial Id: Study for the Knowledge of Risk Factors Associated With Breast Cancer in Women Recruitment Status: Completed Trail description: Breast cancer is the most frequent tumor in Western women. In Spain about 26,000 new breast cancers are diagnosed each year. This type of tumor is increasing worldwide with an inc...
<s>[INST] Provide inclusion criteria for trial id: NCT03918668 [/INST] Older women than 18 years old Newly diagnosed patients with a breast tumor (Phase I, II or III). Being in one of the following cases: Patient who has not yet received any treatment and the committee has decided that as a first treatment will rece...
<s>[INST] Provide exclusion criteria for trial id: NCT03918668 [/INST] Patients with stage IV disease. Associated Eating Disorders. Patients with dementia, mental illness or decreased cognitive function. Pregnant or lactating women. </s>
<s>[INST] Provide description for trial id: NCT03918668 [/INST] Breast cancer is the most frequent tumor in Western women. In Spain about 26,000 new breast cancers are diagnosed each year. This type of tumor is increasing worldwide with an increase in aggressive neoplasms in young women. There are some risk factors re...
<s>[INST] Provide title for trial id: NCT03918668 [/INST] Study for the Knowledge of Risk Factors Associated With Breast Cancer in Women </s>
<s>[INST] Provide the recruitment status for trial id: NCT03918668 [/INST] Completed </s>
<s>[INST] Provide the medical condition for trial id: NCT03918668 [/INST] Breast Neoplasm Female, Nutrition Related Cancer, Habits, Diet, Cancer, Breast </s>
<s>Trial Id: Breast MRI in Women With Known or Suspected Breast Cancer and in Healthy Participants Recruitment Status: Completed Trail description: RATIONALE: Diagnostic procedures, such as MRI, may help diagnose breast cancer. It may also help doctors predict a patient's response to treatment. PURPOSE: This clinical ...
<s>[INST] Provide inclusion criteria for trial id: NCT00474604 [/INST] None </s>
<s>[INST] Provide exclusion criteria for trial id: NCT00474604 [/INST] None </s>
<s>[INST] Provide description for trial id: NCT00474604 [/INST] RATIONALE: Diagnostic procedures, such as MRI, may help diagnose breast cancer. It may also help doctors predict a patient's response to treatment. PURPOSE: This clinical trial is studying breast MRI in women with known or suspected breast cancer and in ...
<s>[INST] Provide title for trial id: NCT00474604 [/INST] Breast MRI in Women With Known or Suspected Breast Cancer and in Healthy Participants </s>
<s>[INST] Provide the recruitment status for trial id: NCT00474604 [/INST] Completed </s>
<s>[INST] Provide the medical condition for trial id: NCT00474604 [/INST] Breast Cancer </s>
<s>Trial Id: Integrative Oncology Outcomes Study in Breast Cancer Recruitment Status: Completed Trail description: This NIH-NCCAM funded epidemiologic research is being conducted as an observational prospective case-control study of the use of Complementary and Alternative Medicine (CAM) and Integrated Oncology (IO) an...
<s>[INST] Provide inclusion criteria for trial id: NCT01366248 [/INST] None </s>
<s>[INST] Provide exclusion criteria for trial id: NCT01366248 [/INST] None </s>
<s>[INST] Provide description for trial id: NCT01366248 [/INST] This NIH-NCCAM funded epidemiologic research is being conducted as an observational prospective case-control study of the use of Complementary and Alternative Medicine (CAM) and Integrated Oncology (IO) and their effects on breast cancer patients in commu...
<s>[INST] Provide title for trial id: NCT01366248 [/INST] Integrative Oncology Outcomes Study in Breast Cancer </s>
<s>[INST] Provide the recruitment status for trial id: NCT01366248 [/INST] Completed </s>
<s>[INST] Provide the medical condition for trial id: NCT01366248 [/INST] Breast Cancer </s>
<s>Trial Id: Characteristics and Treatment Trends of Young Breast Cancer in China Recruitment Status: Not yet recruiting Trail description: To describe the clinical characteristics, the diagnosis and treatment, the survival status and change trend of young breast cancer patients in China from 2000 to 2015, and to explo...
<s>[INST] Provide inclusion criteria for trial id: NCT05068115 [/INST] Young Breast cancer patients (≤35 years old) in China </s>
<s>[INST] Provide exclusion criteria for trial id: NCT05068115 [/INST] Breast cancer patients (>35 years old) in China </s>
<s>[INST] Provide description for trial id: NCT05068115 [/INST] To describe the clinical characteristics, the diagnosis and treatment, the survival status and change trend of young breast cancer patients in China from 2000 to 2015, and to explore and discuss the main influencing factors. </s>
<s>[INST] Provide title for trial id: NCT05068115 [/INST] Characteristics and Treatment Trends of Young Breast Cancer in China </s>
<s>[INST] Provide the recruitment status for trial id: NCT05068115 [/INST] Not yet recruiting </s>
<s>[INST] Provide the medical condition for trial id: NCT05068115 [/INST] Breast Cancer </s>
<s>Trial Id: Study on SBRT for Inoperable Lung and Liver Oligometastases From Breast Cancer Recruitment Status: Unknown status Trail description: Investigators designed a phase II study to evaluate safety and efficacy of lung and liver stereotactic radiation therapy (SRT) in oligometastatic breast cancer patients unsui...
<s>[INST] Provide inclusion criteria for trial id: NCT02581670 [/INST] Patients aged >18 years with ECOG 0-2 Diagnosis of Breast Cancer DFI (Disease-free interval) > 1 year No extrapulmonary and/or extrahepatic disease or other metastatic sites stable or responding after chemotherapy No life threatening conditions Lun...
<s>[INST] Provide exclusion criteria for trial id: NCT02581670 [/INST] ECOG > 2 Pregnant women Patients with inability to consent </s>
<s>[INST] Provide description for trial id: NCT02581670 [/INST] Investigators designed a phase II study to evaluate safety and efficacy of lung and liver stereotactic radiation therapy (SRT) in oligometastatic breast cancer patients unsuitable for surgery, using VMAT RapidArc approach. </s>
<s>[INST] Provide title for trial id: NCT02581670 [/INST] Study on SBRT for Inoperable Lung and Liver Oligometastases From Breast Cancer </s>
<s>[INST] Provide the recruitment status for trial id: NCT02581670 [/INST] Unknown status </s>
<s>[INST] Provide the medical condition for trial id: NCT02581670 [/INST] Breast Cancer, Metastasis to Liver, Metastasis to Lung </s>
<s>Trial Id: A Study to Determine the Clinical Significance of Molecular Detection of Breast Cancer in the Blood of Stage IV Breast Cancer Patients Recruitment Status: Completed Trail description: This study is designed to determine whether molecular detection of breast cancer cells in the peripheral blood of Stage IV ...
<s>[INST] Provide inclusion criteria for trial id: NCT00355316 [/INST] Inclusion Criteria - Stage IV breast cancer patients Patient age must be > 21 years. Patient must have a tissue diagnosis of invasive breast cancer. Patient must have documented evidence of metastatic disease. Patient must have measurable lesions....
<s>[INST] Provide exclusion criteria for trial id: NCT00355316 [/INST] Exclusion Criteria - Stage IV breast cancer patients A patient will be ineligible for inclusion in this study if ANY of the following criteria apply: No documented metastatic disease. No measurable lesions. Bone only and/or brain metastasis. Pati...
<s>[INST] Provide description for trial id: NCT00355316 [/INST] This study is designed to determine whether molecular detection of breast cancer cells in the peripheral blood of Stage IV breast cancer patients is a clinically relevant predictor of progression-free and overall survival. Stage IV breast cancer patients ...
<s>[INST] Provide title for trial id: NCT00355316 [/INST] A Study to Determine the Clinical Significance of Molecular Detection of Breast Cancer in the Blood of Stage IV Breast Cancer Patients </s>
<s>[INST] Provide the recruitment status for trial id: NCT00355316 [/INST] Completed </s>
<s>[INST] Provide the medical condition for trial id: NCT00355316 [/INST] Breast Neoplasms </s>
<s>Trial Id: Sodium (23Na) MRI for Tumour Characterisation and Assessment of Therapy Response in Breast Cancer Recruitment Status: Recruiting Trail description: The scope of this study is the methodological development and optimisation of sodium MRI (23Na-MRI) protocols for breast cancer imaging. The study further prop...
<s>[INST] Provide inclusion criteria for trial id: NCT03940092 [/INST] None </s>
<s>[INST] Provide exclusion criteria for trial id: NCT03940092 [/INST] None </s>
<s>[INST] Provide description for trial id: NCT03940092 [/INST] The scope of this study is the methodological development and optimisation of sodium MRI (23Na-MRI) protocols for breast cancer imaging. The study further proposes to utilise biomarkers obtained from 23Na-imaging (cell integrity), FDG-PET (metabolism), mu...
<s>[INST] Provide title for trial id: NCT03940092 [/INST] Sodium (23Na) MRI for Tumour Characterisation and Assessment of Therapy Response in Breast Cancer </s>
<s>[INST] Provide the recruitment status for trial id: NCT03940092 [/INST] Recruiting </s>
<s>[INST] Provide the medical condition for trial id: NCT03940092 [/INST] Breast Cancer </s>
<s>Trial Id: Triple Negative Breast Cancer: Study of Molecular and Genetic Factors Recruitment Status: Unknown status Trail description: Breast cancer triples negatives (TN; 15 % of the cases) are characterized by a high histoprognostic grade, a strong proliferation, a strong metastatic power, and a worse prognosis tha...
<s>[INST] Provide inclusion criteria for trial id: NCT01434420 [/INST] women > 18 non metastatic breast cancer triple negative 5 years follow-up signed informed consent </s>
<s>[INST] Provide exclusion criteria for trial id: NCT01434420 [/INST] other cancer (except in situ) metastases at diagnosis impossibility of follow-up </s>
<s>[INST] Provide description for trial id: NCT01434420 [/INST] Breast cancer triples negatives (TN; 15 % of the cases) are characterized by a high histoprognostic grade, a strong proliferation, a strong metastatic power, and a worse prognosis than the other forms of breast cancer. It is however a heterogenous group f...
<s>[INST] Provide title for trial id: NCT01434420 [/INST] Triple Negative Breast Cancer: Study of Molecular and Genetic Factors </s>
<s>[INST] Provide the recruitment status for trial id: NCT01434420 [/INST] Unknown status </s>
<s>[INST] Provide the medical condition for trial id: NCT01434420 [/INST] Breast Cancer </s>
<s>Trial Id: Short and Long Term Effects of a Physical Therapy Program After Breast Cancer Surgery Recruitment Status: Suspended Trail description: Objectives: To evaluate the pressure pain threshold, shoulder biomechanics, cardiorespiratory function and the quality of life associated with the short and long-term physi...
<s>[INST] Provide inclusion criteria for trial id: NCT04116281 [/INST] Surgical indication of conservative or removal breast surgery, associated with axillary lymphadenectomy or sentinel lymph node biopsy Any type of breast cancer Age range over 18 years </s>
<s>[INST] Provide exclusion criteria for trial id: NCT04116281 [/INST] Breast cancer recurrence; Surgical treatment for bilateral breast cancer; Presence of lymphedema in the upper limb, measured by means of cirtometry of the upper limb with a measuring tape 14, asymmetries of more than 1.5 cm between the limbs were c...
<s>[INST] Provide description for trial id: NCT04116281 [/INST] Objectives: To evaluate the pressure pain threshold, shoulder biomechanics, cardiorespiratory function and the quality of life associated with the short and long-term physical therapy rehabilitation following breast cancer surgery. Methodology: The study ...
<s>[INST] Provide title for trial id: NCT04116281 [/INST] Short and Long Term Effects of a Physical Therapy Program After Breast Cancer Surgery </s>
<s>[INST] Provide the recruitment status for trial id: NCT04116281 [/INST] Suspended </s>
<s>[INST] Provide the medical condition for trial id: NCT04116281 [/INST] Breast Cancer </s>
<s>Trial Id: Prospective Breast Cancer Biobanking Recruitment Status: Enrolling by invitation Trail description: Prospective Breast Cancer Biobanking study (PBCB) will apply advanced monitoring in liquid biopsies of early staged breast cancer ration in order to facilitate A. Early detection of systemic relapses B.Impro...
<s>[INST] Provide inclusion criteria for trial id: NCT04488614 [/INST] Early stage Breast Cancer DCIS gr III </s>
<s>[INST] Provide exclusion criteria for trial id: NCT04488614 [/INST] Not able to read Norwegian Not able to communicate in Norwegian Previously diagnosed with cancer Dementia </s>
<s>[INST] Provide description for trial id: NCT04488614 [/INST] Prospective Breast Cancer Biobanking study (PBCB) will apply advanced monitoring in liquid biopsies of early staged breast cancer ration in order to facilitate A. Early detection of systemic relapses B.Improve adherence and drug monitoring av tamoxifen tr...
<s>[INST] Provide title for trial id: NCT04488614 [/INST] Prospective Breast Cancer Biobanking </s>
<s>[INST] Provide the recruitment status for trial id: NCT04488614 [/INST] Enrolling by invitation </s>
<s>[INST] Provide the medical condition for trial id: NCT04488614 [/INST] Breast Cancer </s>
<s>Trial Id: The Study of Quadruple Therapy Quercetin, Zinc, Metformin, and EGCG as Adjuvant Therapy for Early, Metastatic Breast Cancer and Triple-negative Breast Cancer, a Novel Mechanism Recruitment Status: Not yet recruiting Trail description: breast cancer is the most common cancer in women. With more than 1 in 10...
<s>[INST] Provide inclusion criteria for trial id: NCT05680662 [/INST] Age above 18 Female patients with any type of breast cancer Ductal carcinoma in situ (DCIS) ... Invasive breast cancer (ILC or IDC) ... Triple-negative breast cancer. ... Inflammatory breast cancer. ... Paget disease of the breast. ... Angiosarcoma...
<s>[INST] Provide exclusion criteria for trial id: NCT05680662 [/INST] Neoadjuvant or adjuvant chemotherapy for this breast cancer prior to enrollment is prohibited. Any of the following due to teratogenic potential of the study drugs: Pregnant women Nursing women Women of childbearing potential who are unwilling to...
<s>[INST] Provide description for trial id: NCT05680662 [/INST] breast cancer is the most common cancer in women. With more than 1 in 10 new cancer diagnoses each year, It is the second most frequent cancer-related death among women worldwide. Breast cancer develops slowly, and the majority of cases are found through ...
<s>[INST] Provide title for trial id: NCT05680662 [/INST] The Study of Quadruple Therapy Quercetin, Zinc, Metformin, and EGCG as Adjuvant Therapy for Early, Metastatic Breast Cancer and Triple-negative Breast Cancer, a Novel Mechanism </s>
<s>[INST] Provide the recruitment status for trial id: NCT05680662 [/INST] Not yet recruiting </s>
<s>[INST] Provide the medical condition for trial id: NCT05680662 [/INST] Breast Cancer Female, Triple Negative Breast Cancer </s>
<s>Trial Id: Evaluation the Diagnostic Ability of the Cancer Detection Technology (CDT) to Detect Breast Cancer Among Women Population Over Age 40 Recruitment Status: Unknown status Trail description: This study aimed to validate the diagnostic ability of the CDT (cancer detection technology) software to detect breast ...
<s>[INST] Provide inclusion criteria for trial id: NCT01043055 [/INST] Inclusion Criteria for Breast Cancer Patients for Experimental Group: Patient is over the age of 40. Patient is willing to participate as evidenced by signing the written informed consent form. Patient referred to the Department of Oncology/ Surge...
<s>[INST] Provide exclusion criteria for trial id: NCT01043055 [/INST] Subjects with any known cancer in other internal organs or systems. Subjects with high fever presentation (more than 38.5). Subjects with known breast disease undergoing treatment for the disease. Pregnant or lactating women </s>
<s>[INST] Provide description for trial id: NCT01043055 [/INST] This study aimed to validate the diagnostic ability of the CDT (cancer detection technology) software to detect breast cancer among women population. </s>
<s>[INST] Provide title for trial id: NCT01043055 [/INST] Evaluation the Diagnostic Ability of the Cancer Detection Technology (CDT) to Detect Breast Cancer Among Women Population Over Age 40 </s>
<s>[INST] Provide the recruitment status for trial id: NCT01043055 [/INST] Unknown status </s>
<s>[INST] Provide the medical condition for trial id: NCT01043055 [/INST] Breast Cancer </s>
<s>Trial Id: Oncoliq: Test for Early Breast Cancer Detection. Recruitment Status: Recruiting Trail description: Oncoliq is a novel early breast cancer detection test based on liquid biopsies and microRNAs. This innovative test will allow improving the accuracy of cancer detection which will impact on health, reducing t...
<s>[INST] Provide inclusion criteria for trial id: NCT04906330 [/INST] Women patients performing gynecological control Between 50-70 years old Without personal history of oncological disease Informed consent signed </s>
<s>[INST] Provide exclusion criteria for trial id: NCT04906330 [/INST] Patients who don´t meet the inclusion criteria. Active infection with SARS-CoV-2 (COVID-19). </s>
<s>[INST] Provide description for trial id: NCT04906330 [/INST] Oncoliq is a novel early breast cancer detection test based on liquid biopsies and microRNAs. This innovative test will allow improving the accuracy of cancer detection which will impact on health, reducing the patient mortality and health costs. To deve...
<s>[INST] Provide title for trial id: NCT04906330 [/INST] Oncoliq: Test for Early Breast Cancer Detection. </s>